Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 679

1.

Measurement of urinary 5-HIAA: correlation between spot versus 24-hour urine collection.

Calanchini M, Tadman M, Krogh J, Fabbri A, Grossman A, Shine B.

Endocr Connect. 2019 Jul 1. pii: EC-19-0269. doi: 10.1530/EC-19-0269. [Epub ahead of print]

2.
3.

Changes in chemical profile of Cascade hop cones according to the growing area.

Rodolfi M, Chiancone B, Liberatore CM, Fabbri A, Cirlini M, Ganino T.

J Sci Food Agric. 2019 Jun 19. doi: 10.1002/jsfa.9876. [Epub ahead of print]

PMID:
31216060
4.

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial.

Perrone F, De Laurentiis M, De Placido S, Orditura M, Cinieri S, Riccardi F, Ribecco AS, Putzu C, Del Mastro L, Rossi E, Tinessa V, Mosconi AM, Nuzzo F, Di Rella F, Gravina A, Iodice G, Landi G, Pacilio C, Forestieri V, Lauria R, Fabbri A, Ibrahim T, De Maio E, Barni S, Gori S, Simeon V, Arenare L, Daniele G, Piccirillo MC, Normanno N, de Matteis A, Gallo C.

Eur J Cancer. 2019 Jun 1. pii: S0959-8049(19)30297-7. doi: 10.1016/j.ejca.2019.05.004. [Epub ahead of print]

PMID:
31164265
5.

Eye Drop Instillation of the Rac1 Modulator CNF1 Attenuates Retinal Gliosis and Ameliorates Visual Performance in a Rat Model of Hypertensive Retinopathy.

Matteucci A, Ricceri L, Fabbri A, Fortuna A, Travaglione S, Guidotti M, Martinelli A, Villa M, Pricci F, Maroccia Z, Campana G, Malchiodi-Albedi F, Fiorentini C, Loizzo S.

Neuroscience. 2019 Jul 15;411:119-129. doi: 10.1016/j.neuroscience.2019.05.021. Epub 2019 May 23.

PMID:
31128161
6.

Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, Mariani S, Lubrano C, Poggiogalle E, Migliaccio S, Donini LM, Basciani S, Cignarelli A, Conte E, Ceccarini G, Bogazzi F, Cimino L, Condorelli RA, La Vignera S, Calogero AE, Gambineri A, Vignozzi L, Prodam F, Aimaretti G, Linsalata G, Buralli S, Monzani F, Aversa A, Vettor R, Santini F, Vitti P, Gnessi L, Pagotto U, Giorgino F, Colao A, Lenzi A; Cardiovascular Endocrinology Club of the Italian Society of Endocrinology.

J Endocrinol Invest. 2019 May 20. doi: 10.1007/s40618-019-01061-2. [Epub ahead of print]

PMID:
31111407
7.

Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis.

Chartres N, Fabbri A, McDonald S, Turton J, Allman-Farinelli M, McKenzie J, Bero L.

BMJ Open. 2019 May 19;9(5):e022912. doi: 10.1136/bmjopen-2018-022912.

8.

A protocol for the development of a prediction model in mild traumatic brain injury with CT scan abnormality: which patients are safe for discharge?

Marincowitz C, Lecky FE, Townend W, Allgar V, Fabbri A, Sheldon TA.

Diagn Progn Res. 2018 Apr 20;2:6. doi: 10.1186/s41512-018-0027-4. eCollection 2018.

9.

Extracts from Cell Suspension Cultures of Strawberry (Fragaria x ananassa Duch): Cytotoxic Effects on Human Cancer Cells.

Lucioli S, Pastorino F, Nota P, Ballan G, Frattarelli A, Fabbri A, Forni C, Caboni E.

Molecules. 2019 May 4;24(9). pii: E1738. doi: 10.3390/molecules24091738.

10.

Voltage-tunable dual-band Ge/Si photodetector operating in VIS and NIR spectral range.

Simola ET, De Iacovo A, Frigerio J, Ballabio A, Fabbri A, Isella G, Colace L.

Opt Express. 2019 Mar 18;27(6):8529-8539. doi: 10.1364/OE.27.008529.

PMID:
31052668
11.

Comment on "mineralocorticoid antagonism enhances brown adipose tissue function in humans: A randomized placebo-controlled cross-over study".

Armani A, Infante M, Fabbri A, Caprio M.

Diabetes Obes Metab. 2019 Aug;21(8):2024-2026. doi: 10.1111/dom.13756. Epub 2019 May 26. No abstract available.

PMID:
31050122
12.

Comparative Analysis of Medicines Safety Advisories Released by Australia, Canada, the United States, and the United Kingdom.

Perry LT, Bhasale A, Fabbri A, Lexchin J, Puil L, Joarder M, Mintzes B.

JAMA Intern Med. 2019 Apr 29. doi: 10.1001/jamainternmed.2019.0294. [Epub ahead of print] No abstract available.

PMID:
31033999
13.

VITAL study: an incomplete picture?

Infante M, Ricordi C, Baidal DA, Alejandro R, Lanzoni G, Sears B, Caprio M, Fabbri A.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):3142-3147. doi: 10.26355/eurrev_201904_17599. No abstract available.

14.

Response to "A Rigorous Evaluation of Methoxyflurane is Needed: Comment on 'Methoxyflurane Versus Standard of Care for Acute Trauma-Related Pain in the Emergency Setting: Protocol for a Randomised, Controlled Study in Italy (MEDITA)'".

Fabbri A, Carpinteri G, Ruggiano G, Bonafede E, Sblendido A, Farina A, Soldi A.

Adv Ther. 2019 Jun;36(6):1243-1245. doi: 10.1007/s12325-019-00937-2. Epub 2019 Mar 30. No abstract available.

PMID:
30929187
15.

Medical donations are not always free: an assessment of compliance of medicine and medical device donations with World Health Organization guidelines (2009-2017).

McDonald S, Fabbri A, Parker L, Williams J, Bero L.

Int Health. 2019 Mar 21. pii: ihz004. doi: 10.1093/inthealth/ihz004. [Epub ahead of print]

PMID:
30916303
16.

Secret safety warnings on medicines: A case study of information access requests.

Torka M, Mintzes B, Bhasale A, Fabbri A, Perry L, Lexchin J.

Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):551-555. doi: 10.1002/pds.4762. Epub 2019 Mar 6.

PMID:
30840349
17.

Adipocyte Mineralocorticoid Receptor.

Infante M, Armani A, Marzolla V, Fabbri A, Caprio M.

Vitam Horm. 2019;109:189-209. doi: 10.1016/bs.vh.2018.10.005. Epub 2018 Dec 21. Review.

PMID:
30678856
18.

Pharmaceutical Industry Funding of Health Consumer Groups in Australia: A Cross-sectional Analysis.

Fabbri A, Swandari S, Lau E, Vitry A, Mintzes B.

Int J Health Serv. 2019 Apr;49(2):273-293. doi: 10.1177/0020731418823376. Epub 2019 Jan 15.

PMID:
30646806
19.

RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.

Infante M, Fabi A, Cognetti F, Gorini S, Caprio M, Fabbri A.

J Exp Clin Cancer Res. 2019 Jan 8;38(1):12. doi: 10.1186/s13046-018-1001-2. Review.

20.

Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial.

Vernieri C, Signorelli D, Galli G, Ganzinelli M, Moro M, Fabbri A, Tamborini E, Marabese M, Caiola E, Broggini M, Hollander L, Gallucci R, Vandoni G, Gavazzi C, Triulzi T, Colombo MP, Rizzo AM, Corsetto PA, Pruneri G, de Braud F, Sozzi G, Torri V, Garassino MC.

Clin Lung Cancer. 2019 May;20(3):e413-e417. doi: 10.1016/j.cllc.2018.12.011. Epub 2018 Dec 19.

PMID:
30617039
21.

Freshness assessment of European hake (Merluccius merluccius) through the evaluation of eye chromatic and morphological characteristics.

Rocculi P, Cevoli C, Tappi S, Genovese J, Urbinati E, Picone G, Fabbri A, Capozzi F, Rosa MD.

Food Res Int. 2019 Jan;115:234-240. doi: 10.1016/j.foodres.2018.08.091. Epub 2018 Aug 28.

PMID:
30599937
22.

Prognostic significance of lymphocyte/monocyte count and neutrophil/lymphocyte count in peripheral T cell lymphoma.

Cencini E, Fabbri A, Sicuranza A, Bocchia M.

Leuk Res. 2019 Feb;77:5-7. doi: 10.1016/j.leukres.2018.12.008. Epub 2018 Dec 22. No abstract available.

PMID:
30594867
23.

The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures.

Bero L, Chartres N, Diong J, Fabbri A, Ghersi D, Lam J, Lau A, McDonald S, Mintzes B, Sutton P, Turton JL, Woodruff TJ.

Syst Rev. 2018 Dec 21;7(1):242. doi: 10.1186/s13643-018-0915-2.

24.

Omega-3 PUFAs and vitamin D co-supplementation as a safe-effective therapeutic approach for core symptoms of autism spectrum disorder: case report and literature review.

Infante M, Sears B, Rizzo AM, Mariani Cerati D, Caprio M, Ricordi C, Fabbri A.

Nutr Neurosci. 2018 Dec 13:1-12. doi: 10.1080/1028415X.2018.1557385. [Epub ahead of print]

25.

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.

Pizzuti L, Giordano A, Michelotti A, Mazzotta M, Natoli C, Gamucci T, De Angelis C, Landucci E, Diodati L, Iezzi L, Mentuccia L, Fabbri A, Barba M, Sanguineti G, Marchetti P, Tomao S, Mariani L, Paris I, Lorusso V, Vallarelli S, Cassano A, Airoldi F, Orlandi A, Moscetti L, Sergi D, Sarobba MG, Tonini G, Santini D, Sini V, Veltri E, Vaccaro A, Ferrari L, De Tursi M, Tinari N, Grassadonia A, Greco F, Botticelli A, La Verde N, Zamagni C, Rubino D, Cortesi E, Magri V, Pomati G, Scagnoli S, Capomolla E, Kayal R, Scinto AF, Corsi D, Cazzaniga M, Laudadio L, Forciniti S, Mancini M, Carbognin L, Seminara P, Barni S, Samaritani R, Roselli M, Portarena I, Russo A, Ficorella C, Cannita K, Carpano S, Pistelli M, Berardi R, De Maria R, Sperduti I, Ciliberto G, Vici P.

J Cell Physiol. 2019 Jun;234(6):7708-7717. doi: 10.1002/jcp.27832. Epub 2018 Dec 10.

PMID:
30536609
26.

Rapid rule-out of suspected acute coronary syndrome in the Emergency Department by high-sensitivity cardiac troponin T levels at presentation.

Fabbri A, Bachetti C, Ottani F, Morelli A, Benazzi B, Spiezia S, Cortigiani M, Dorizzi R, Jaffe AS, Galvani M.

Intern Emerg Med. 2019 Apr;14(3):403-410. doi: 10.1007/s11739-018-1996-6. Epub 2018 Nov 29.

PMID:
30499074
27.

Methoxyflurane Versus Standard of Care for Acute Trauma-Related Pain in the Emergency Setting: Protocol for a Randomised, Controlled Study in Italy (MEDITA).

Fabbri A, Carpinteri G, Ruggiano G, Bonafede E, Sblendido A, Farina A, Soldi A; MEDITA Study Group.

Adv Ther. 2019 Jan;36(1):244-256. doi: 10.1007/s12325-018-0830-x. Epub 2018 Nov 22.

28.

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.

Visco C, Tisi MC, Evangelista A, Di Rocco A, Zoellner AK, Zilioli VR, Hohaus S, Sciarra R, Re A, Tecchio C, Chiappella A, Morello L, Gini G, Nassi L, Perrone T, Molinari AL, Fabbri A, Cox MC, Finolezzi E, Ferrero S, Puccini B, Alvarez De Celis I, Arcari A, Marino D, Merli M, Piazza F, Gentile M, Pelosini M, Loseto G, Hermine O, Dreyling M, Ruggeri M, Martelli M, Hoster E, Vitolo U; Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network.

Br J Haematol. 2019 Jun;185(5):940-944. doi: 10.1111/bjh.15643. Epub 2018 Nov 8. No abstract available.

PMID:
30407625
29.

Validation of the BAP-65 score for prediction of in-hospital death or use of mechanical ventilation in patients presenting to the emergency department with an acute exacerbation of COPD: a retrospective multi-center study from the Italian Society of Emergency Medicine (SIMEU).

Germini F, Veronese G, Marcucci M, Coen D, Ardemagni D, Montano N, Fabbri A; SIMEU Study Group.

Eur J Intern Med. 2019 Mar;61:62-68. doi: 10.1016/j.ejim.2018.10.018. Epub 2018 Oct 31.

PMID:
30391167
30.

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).

Imbimbo M, Ottaviano M, Vitali M, Fabbri A, Leuzzi G, Fiore M, Franceschini D, Pasello G, Perrino M, Schiavon M, Pruneri G, Dei Tos AP, Sangalli C, Garassino MC, Berardi R, Alessi A, Calareso G, Petrini I, Scorsetti M, Scotti V, Rosso L, Rea F, Pastorino U, Casali PG, Ramella S, Ricardi U, Abate-Daga L, Torri V, Trama A, Palmieri G, Marino M, Zucali PA; TYME network collaborators.

Cancer Treat Rev. 2018 Dec;71:76-87. doi: 10.1016/j.ctrv.2018.10.001. Epub 2018 Oct 5.

PMID:
30366202
31.

The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.

Fabbri A, Lai A, Grundy Q, Bero LA.

Am J Public Health. 2018 Nov;108(11):e9-e16. doi: 10.2105/AJPH.2018.304677. Epub 2018 Sep 25.

32.

Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma.

Cencini E, Fabbri A, Schiattone L, Bocchia M.

Leuk Lymphoma. 2019 Mar;60(3):833-835. doi: 10.1080/10428194.2018.1504938. Epub 2018 Sep 20. No abstract available.

PMID:
30234387
33.

Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab.

Cencini E, Sicuranza A, Fabbri A, Ferrigno I, Rigacci L, Cox MC, Raspadori D, Bocchia M.

Br J Haematol. 2019 Jan;184(2):223-231. doi: 10.1111/bjh.15582. Epub 2018 Sep 11.

PMID:
30203425
34.

Food industry sponsorship of academic research: investigating commercial bias in the research agenda.

Fabbri A, Holland TJ, Bero LA.

Public Health Nutr. 2018 Dec;21(18):3422-3430. doi: 10.1017/S1368980018002100. Epub 2018 Aug 30.

PMID:
30157979
35.

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer.

Fabi A, Alesini D, Valle E, Moscetti L, Caputo R, Caruso M, Carbognin L, Ciccarese M, La Verde N, Arpino G, Cannita K, Paris I, Santini D, Montemurro F, Russillo M, Ferretti G, Filippelli G, Rossello R, Fabbri A, Zambelli A, Leonardi V, D'Ottavio AM, Nisticò C, Stani S, Giampaglia M, Scandurra G, Catania G, Malaguti P, Giannarelli D, Cognetti F.

Breast. 2018 Oct;41:137-143. doi: 10.1016/j.breast.2018.07.004. Epub 2018 Jul 12.

PMID:
30092500
36.

RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients.

Tessari A, Parbhoo K, Pawlikowski M, Fassan M, Rulli E, Foray C, Fabbri A, Embrione V, Ganzinelli M, Capece M, Campbell MJ, Broggini M, La Perle K, Farina G, Cole S, Marabese M, Hernandez M, Amann JM, Pruneri G, Carbone DP, Garassino MC, Croce CM, Palmieri D, Coppola V.

Oncogene. 2018 Dec;37(50):6463-6476. doi: 10.1038/s41388-018-0424-8. Epub 2018 Aug 3.

PMID:
30076413
37.

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.

Imbimbo M, Vitali M, Fabbri A, Ottaviano M, Pasello G, Petrini I, Palmieri G, Berardi R, Zucali P, Ganzinelli M, Marabese M, Broggini M, Marino M, Trama A, Rulli E, Hollander L, Pruneri G, Torri V, Garassino MC.

Clin Lung Cancer. 2018 Sep;19(5):e811-e814. doi: 10.1016/j.cllc.2018.06.005. Epub 2018 Jul 3.

PMID:
30033090
38.

How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional study.

Lau E, Fabbri A, Mintzes B.

Aust Health Rev. 2018 Jul 19. doi: 10.1071/AH17288. [Epub ahead of print]

PMID:
30021681
39.

Liver biochemical abnormalities in Turner syndrome: A comprehensive characterization of an adult population.

Calanchini M, Moolla A, Tomlinson JW, Cobbold JF, Grossman A, Fabbri A, Turner HE.

Clin Endocrinol (Oxf). 2018 Nov;89(5):667-676. doi: 10.1111/cen.13811. Epub 2018 Aug 19.

PMID:
29992593
40.

Primary CNS lymphoma: latest updates and a 10-year monocenter experience.

Cencini E, Fabbri A, Schiattone L, Cerase A, Bocchia M.

Blood Res. 2018 Jun;53(2):174-177. doi: 10.5045/br.2018.53.2.174. Epub 2018 Jun 25. No abstract available.

41.

MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients.

Ambrosio MR, Lazzi S, Bello GL, Santi R, Porro LD, de Santi MM, Guazzo R, Mundo L, Rigacci L, Kovalchuck S, Onyango N, Fabbri A, Cencini E, Zinzani PL, Zaja F, Angrilli F, Stelitano C, Cabras MG, Spataro G, Bob R, Menter T, Granai M, Cevenini G, Naresh KN, Stein H, Sabattini E, Leoncini L.

Haematologica. 2019 Jan;104(1):e25-e28. doi: 10.3324/haematol.2018.195958. Epub 2018 Jun 28. No abstract available.

42.

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries.

Fabbri A, Santos A, Mezinska S, Mulinari S, Mintzes B.

Int J Health Policy Manag. 2018 Mar 14;7(6):504-509. doi: 10.15171/ijhpm.2018.20.

43.

The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study.

Fabbri A, Travaglione S, Maroccia Z, Guidotti M, Pierri CL, Primiano G, Servidei S, Loizzo S, Fiorentini C.

Int J Mol Sci. 2018 Jun 21;19(7). pii: E1825. doi: 10.3390/ijms19071825.

44.

Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality.

de Rezende LFM, Rey-López JP, de Sá TH, Chartres N, Fabbri A, Powell L, Stamatakis E, Bero L.

PLoS Biol. 2018 Jun 18;16(6):e2005761. doi: 10.1371/journal.pbio.2005761. eCollection 2018 Jun.

45.

Cell Propagation of Cholera Toxin CTA ADP-Ribosylating Factor by Exosome Mediated Transfer.

Zanetti C, Gallina A, Fabbri A, Parisi S, Palermo A, Fecchi K, Boussadia Z, Carollo M, Falchi M, Pasquini L, Fiani ML, Sargiacomo M.

Int J Mol Sci. 2018 May 19;19(5). pii: E1521. doi: 10.3390/ijms19051521.

46.

Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.

Storti S, Spina M, Pesce EA, Salvi F, Merli M, Ruffini A, Cabras G, Chiappella A, Angelucci E, Fabbri A, Liberati AM, Tani M, Musuraca G, Molinari A, Petrilli MP, Palladino C, Ciancia R, Ferrario A, Gasbarrino C, Monaco F, Fraticelli V, De Vellis A, Merli F, Luminari S.

Haematologica. 2018 Aug;103(8):1345-1350. doi: 10.3324/haematol.2017.186569. Epub 2018 May 10.

47.

The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells.

Gall-Mas L, Fabbri A, Namini MRJ, Givskov M, Fiorentini C, Krejsgaard T.

Int J Mol Sci. 2018 May 8;19(5). pii: E1408. doi: 10.3390/ijms19051408.

48.

New therapeutics from Nature: The odd case of the bacterial cytotoxic necrotizing factor 1.

Maroccia Z, Loizzo S, Travaglione S, Frank C, Fabbri A, Fiorentini C.

Biomed Pharmacother. 2018 May;101:929-937. doi: 10.1016/j.biopha.2018.02.140. Epub 2018 Mar 22. Review.

PMID:
29635902
49.

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2018 Feb 27;8(1):3965. doi: 10.1038/s41598-018-21279-z.

50.

Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases.

Bonucci M, Pastore C, Ferrera V, Fiorentini C, Fabbri A.

Integr Cancer Ther. 2018 Sep;17(3):994-999. doi: 10.1177/1534735418755479. Epub 2018 Feb 25.

Supplemental Content

Loading ...
Support Center